301211 亨迪药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.5737.6025.5928.32328.280
总资产报酬率 ROA (%)1.4696.9815.2107.76421.703
投入资产回报率 ROIC (%)1.5517.4095.4778.24426.103

边际利润分析
销售毛利率 (%)37.91640.17228.87833.94349.650
营业利润率 (%)32.11730.96928.88425.76433.556
息税前利润/营业总收入 (%)19.25622.95515.96726.04035.102
净利润/营业总收入 (%)27.07726.56224.43022.50228.346

收益指标分析
经营活动净收益/利润总额(%)97.20796.29694.03384.77596.151
价值变动净收益/利润总额(%)2.2161.9820.0007.6912.816
营业外收支净额/利润总额(%)-0.039-1.242-0.871-0.073-0.165

偿债能力分析
流动比率 (X)15.47011.98410.66020.6706.092
速动比率 (X)14.21310.99210.11119.8024.734
资产负债率 (%)5.7957.4578.8954.61412.805
带息债务/全部投入资本 (%)0.7310.9322.9850.271--
股东权益/带息债务 (%)13,498.18610,560.3443,230.84136,672.9365,114.783
股东权益/负债合计 (%)1,625.5771,241.1041,024.2712,067.151680.967
利息保障倍数 (X)-1.499-3.007-1.26088.47721.911

营运能力分析
应收账款周转天数 (天)40.01533.69670.74872.6240.000
存货周转天数 (天)179.249130.916100.365112.9460.000